Agilon Health
205 hedge funds and large institutions have $933M invested in Agilon Health in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 80 increasing their positions, 47 reducing their positions, and 26 closing their positions.
70% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 47
49% more call options, than puts
Call options by funds: $4.26M | Put options by funds: $2.86M
38% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 26
4% more funds holding
Funds holding: 197 → 205 (+8)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.03% less ownership
Funds ownership: 3.95% → 3.92% (-0.03%)
49% less capital invested
Capital invested by funds: $1.82B → $933M (-$888M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$64.9M |
| 2 |
Morgan Stanley
New York
|
+$16.7M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$5.89M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$4.63M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$4.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$39.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$35.3M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$25.1M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$13.4M |
| 5 |
Millennium Management
New York
|
-$8.6M |
AGL Hedge Fund Activity: Q2 2025 in Review
205 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q2 2025, worth a combined $933M — down 49% from $1.82B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new AGL positions and 26 closed out — a net gain of 10 holders — while 80 added to existing stakes and 47 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $64.9M. The largest seller was Capital International Investors, cutting an estimated $39.9M.
- 205 institutional investors held Agilon Health (AGL) as of Q2 2025, up from 197 in Q1 2025.
- Funds reported $933M of Agilon Health stock for Q2 2025, down 49% quarter-over-quarter.
- 36 funds opened new Agilon Health positions in Q2 2025 and 26 closed out, a net change of +10 holders.
- The largest Agilon Health buyer in Q2 2025 was Fidelity Investments, an estimated $64.9M added.
- The largest Agilon Health seller in Q2 2025 was Capital International Investors, an estimated $39.9M sold.
Based on aggregated 13F filings for Q2 2025.